Front. Immunol. Frontiers in Immunology Front. Immunol. 1664-3224 Frontiers Media S.A. 10.3389/fimmu.2023.1172427 Immunology Erratum Erratum: Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies AparicioBelén 1 2 3 RuizMarta 1 2 3 CasaresNoelia 1 3 SilvaLeyre 1 2 3 EgeaJosune 1 2 3 PérezPatricia 4 5 AlbericioGuillermo 4 EstebanMariano 4 García-ArriazaJuan 4 5 LasarteJuan J. 1 3 * SarobePablo 1 2 3 * 1Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra, Pamplona, Spain 2Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Pamplona, Spain 3Instituto de Investigaciones Sanitarias de Navarra (IdiSNA), Pamplona, Spain 4Centro Nacional de Biotecnología (CNB), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain 5Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

*Correspondence: Juan J. Lasarte, jjlasarte@unav.es; Pablo Sarobe, psarobe@unav.es

This article was submitted to Vaccines and Molecular Therapeutics, a section of the journal Frontiers in Immunology

 03 03 2023 2023 14 1172427 23 02 2023 23 02 2023 Copyright © 2023 Aparicio, Ruiz, Casares, Silva, Egea, Pérez, Albericio, Esteban, García-Arriaza, Lasarte and Sarobe 2023 Aparicio, Ruiz, Casares, Silva, Egea, Pérez, Albericio, Esteban, García-Arriaza, Lasarte and Sarobe

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 An Erratum on Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies by Aparicio B, Ruiz M, Casares N, Silva L, Egea J, Pérez P, Albericio G, Esteban M, García-Arriaza J, Lasarte JJ and Sarobe P (2023) Front. Immunol. 13:1044025. doi: 10.3389/fimmu.2022.1044025 SARS-CoV-2 peptide vaccine Omicron variant cross-recognizing antibodies conserved regions

Due to a production error, the Author Contributions statement was not updated to accurately reflect the contributions of the newly added authors PP, GA, JG-A and ME. The correct Author Contributions statement appears below.

Author contributions

“BA, JL and PS conceived and designed experiments. BA, MR, NC, LS, JE, PP, GA and JG-A performed the in silico, in vitro and in vivo studies. BA, PP, GA, JG-A, ME, JL and PS analyzed data and contributed to their interpretation. JL and PS supervised the project. ME, JG-A, JL and PS received funding. All authors reviewed the manuscript, approved the final version to be published and agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.”

The publisher apologizes for this mistake. The original article has been updated.